Stanford University
Showing 301-400 of 777 Results
-
Niushen Zhang
Clinical Associate Professor, Adult Neurology
BioDr. Niushen Zhang is a board-certified neurologist and Chief of the Headache and Facial Pain Division in the Department of Neurology. She has a special interest in developing personalized treatment plans for headache patients which incorporate the use of complementary and integrative medicine. She is the Chair of the Complementary and Integrative Medicine Special Interest Section of the American Headache Society (AHS). Her research interests include the connection between the gut microbiome and migraine and the impact of diet and nutrition on migraine. In addition, she participates in clinical trials of new headache treatments for migraine and cluster headache. Dr. Zhang is also actively involved in medical education. She is the Director of the Headache Fellowship Program at Stanford. She serves as the Co-Chair of the Headache Fellowship Directors Committee for the American Headache Society (AHS). She is also a curriculum developer for AHS's REACH Program. She spearheaded the design and creation of the AHS National Headache Fellowship Opportunities website which serves as a central resource for all headache fellowship applicants and promotes the AAN's unified fellowship application timeline.
Dr. Zhang graduated from Yale University with a Bachelor of Science degree in Molecular, Cellular and Developmental Biology. She earned an MD from the New York University School of Medicine. She completed neurology residency and fellowship in headache and facial pain at Stanford University. -
Peng Zhang
Visiting Postdoctoral Scholar, Cardiovascular Institute Operations
BioI am a visiting postdoctoral scholar at Stanford University, specializing in Dr. Nguyen’s lab. I am a PhD in Integrative Medicine with research focus on elucidating the molecular and cellular mechanisms underlying immune-metabolic disorders, including but not limited to cardiovascular diseases, bone diseases, and autoimmune diseases. My work integrates traditional Chinese medicine (TCM) theories with modern biomedical approaches, employing techniques such as multi-omics analysis, network pharmacology, and in vivo/in vitro disease modeling to explore novel therapeutic strategies and biomarker discovery.
-
Rachel (Yinghao) Zhang
Managing Director of Industry Partnerships, Stanford SystemX Alliance, Electrical Engineering
BioRachel is the Managing Director of Industry Partnerships at SystemX.
As an innovative business leader, Rachel has launched and expanded businesses across the U.S., Asia, and global markets for tech companies including Alibaba, Ant Group, and Microchip.
During her tenure as Senior Advisor at Ant Group, she also incubated a philanthropic initiative to cultivate 10,000 technology leaders over a decade, aiming to bridge the digital divide and drive economic growth in emerging markets.
Rachel is passionate about harnessing technology for good, driving innovation, and bridging industry collaboration to create a broader meaningful impact.
Rachel is a Stanford GSB alumna. -
Ray Rui Zhang
Adjunct Clinical Instructor, Radiology - Rad/Nuclear Medicine
BioBackground:
Ray Zhang grew up in Chicago, Illinois. He attended to UC Berkeley, where he majored in Chemical Biology. He then joined the Medical Scientist Training Program at the University of Wisconsin - Madison School of Medicine and Public Health, and earned his combined MD and PhD degrees. He completed his doctoral studies in the field of molecular imaging in the laboratories of Jamey Weichert and John Kuo, developing novel radiotracers for targeted cancer imaging and therapy.
His career interest involves continued leadership, activism, and translational research in the area of molecular imaging and therapy.
-------------------------------
Education and Training:
Stanford University Medical Center, Palo Alto CA
Resident Physician, Department of Radiology (2020 - present)
Loyola Medical Center, Maywood IL
Resident Physician, Internal Medicine (6/2019-6/2020)
University of Wisconsin, Madison WI
M.D. (7/2011-5/2019)
Ph.D. Cellular and Molecular Biology (8/2013 – 6/2017)
Dissertation: Next Generation Alkylphosphocholine Analogs for Multimodality Imaging and Therapy of Cancer
Advisor: Jamey Weichert, Ph.D., John Kuo, M.D., Ph.D., F.A.C.S.
Project: Synthesis, characterization and preclinical imaging of tumor-targeted platform agents for intraoperative fluorescence-guided surgery, positron emission tomography, magnetic resonance imaging, and targeted radiotherapy
University of California, Berkeley CA
B.S., Highest Honors, Chemical Biology (2006 – 2009)
William C. Braye Scholar 2006-2009
----------------------------------
Honors and Leadership Positions:
Lovell Memorial Scholarship for Excellence in Academic Radiology (2019)
Department of Radiology, University of Wisconsin. Madison, WI
Seminar Chair, Medical Scientist Training Program (2014-2015)
University of Wisconsin. Madison, WI
Keynote Speaker at Gray Matters Fundraiser Event
Foundation in Support for Brain Cancer. Madison WI (2014)
Secretary, Asian Pacific American Medical Student Association (2013-2014)
University of Wisconsin, School of Medicine and Public Health. Madison, WI
Treasurer, Asian Pacific American Medical Student Association (2012-2013)
University of Wisconsin, School of Medicine and Public Health. Madison, WI
Medical Scientist Training Program (2011-2019)
University of Wisconsin, School of Medicine and Public Health. Madison, WI
Co-founder, American Physician Scientist Association, Wisconsin Chapter (2013-2014)
University of Wisconsin, School of Medicine and Public Health. Madison, WI
Treasurer, American Physician Scientist Association, Wisconsin Chapter (2013-2014)
University of Wisconsin, School of Medicine and Public Health. Madison, WI
Teaching Assitant/Mentorship Achievement Award in Biological Sciences (2014)
Department of Cellular and Molecular Biology. University of Wisconsin-Madison
SPARK Research Fellow, H. Lee Moffitt Cancer and Research Institute (2007-2008)
Moffitt Cancer Center, Tampa, FL
Highest Honors in Chemical Biology (2009)
University of California, Berkeley
Dean’s List (2006-2009)
University of California, Berkeley
William C. Braye Scholarship for Excellence in Chemistry (2006-2009)
University of California, Berkeley
--------------------------
Publications/Patents:
https://scholar.google.com/citations?user=yfG6A8MAAAAJ&hl=en -
Sha Zhang
Research Administrator, Medicine - Med/Immunology & Rheumatology
Current Role at StanfordFinancial Analyst
-
Shu Zhang
Postdoctoral Scholar, Pathology
BioMy research interest is the correlation between tumor heterogeneity and ecDNA, especially related to drug resistance.
-
Sydney Zhang
Undergraduate, Vice Provost for Undergraduate Education
BioORCID Publications: https://orcid.org/0000-0002-7924-9049
-
Tian Yi Zhang, MD, PhD
Assistant Professor of Medicine (Hematology)
BioDr. Zhang is a board-certified hematologist. She is also an assistant professor of hematology at Stanford University School of Medicine. In addition to her medical degree, she holds a PhD in cellular and molecular immunology.
In her clinical practice, she treats patients with all forms of hematological malignancies, offering specialized expertise in acute myeloid leukemia, including therapy-resistant cases. For each patient, she develops a personalized care plan encompassing novel treatment options.
Her research activities include conducting early phase clinical trials, investigator initiated clinical trials (IITs), studying the immune repertoire in patients with myeloid malignancies, and exploring cholesterol metabolic dependencies of acute myeloid leukemia (AML).
She was the recipient of an A.P. Giannini Foundation fellowship award, which supports innovative research. The award helped fund Dr. Zhang’s study of how AML cells interact with other cells in bone marrow. A significant finding confirmed that AML cells secrete a protein that suppresses the production of red blood cells, the same protein that causes inflammation in disorders such as rheumatoid arthritis and Crohn’s disease.
Her many other honors include the National Cancer Institute Career Development (K08) Award, the American Society of Hematology (ASH) Research Training Award for Fellows, Stanford Cancer Institute - American Cancer Society (SCI-ACS) Pilot Grant and Best ASH Abstract Award two years in a row. She also has earned recognition from the National Institutes of Health and American College of Physicians.
She has published her research findings on topics such as advanced therapy for high-risk myelodysplastic syndromes and reversal of bone marrow failure induced by AML. Her work has appeared in Leukemia & Lymphoma, Science Translational Medicine, Cancer Research, the Journal of Clinical Investigation, Journal of Immunology, and elsewhere.
Dr. Zhang is a member of the American Association of Cancer Research and American Society of Hematology. She advises and mentors Stanford medical students, residents and fellows. She delivers invited lectures to faculty and fellows. In addition, she has been an invited speaker on the topic of acute myeloid leukemia at the Association of Northern California Oncologists Update on Hematological Malignancies. -
Weiruo Zhang
Affiliate, Biomedical Data Science
BioDr. Zhang is currently a research engineer at the Department of Biomedical Data Science, and the data manager in the Center for Cancer Systems Biology at Stanford. Dr. Zhang completed her M.S. and Ph.D. in Electrical Engineering, both from Stanford University. Her Ph.D. studies focused on developing machine learning (ML) algorithms for metabolomics data analysis using graph theory. She received Young Scientist Award from the Metabolomics Society for her algorithm on metabolic network analysis delineating the effects of genetic mutants and drug treatment on the metabolome. Her postdoctoral studies at the Department of Radiology, Stanford School of Medicine, integrated radiomic, genomic, transcriptomic, histopathologic and clinical data that identified a prognostic metabolic regulation biomarker for non-small cell lung cancer. She has developed open-source computational tools that have been appreciated by the broad research community and industry, including the CELESTA algorithm which has been incorporated into commercial analytical platform of NanoString. Dr. Zhang's research has made significant impacts in the fields of spatial multi-omics and cancer systems biology, and she has authored and co-authored publications including Cell, Nature Methods, Nature Communications etc.
Dr. Zhang's current research at Stanford primarily focuses on developing and implementing ML/AI approaches to integrate and analyze multi-modality data, including spatial multi-omics, radiologic imaging, histopathologic images and clinical data. Her research aims at bridging the gap between underlying disease molecular/cellular biology and clinical assessment to improve diagnostics, prognostics and treatment strategies. -
Wubing Zhang
Postdoctoral Scholar, Stem Cell Biology and Regenerative Medicine
Current Research and Scholarly InterestsI'm interested in developing innovative methods and integrating multi-omics data to understand tumor-immune regulation and identify potential targets for cancer therapy.
-
Xingyuan Zhang
Ph.D. Student in Chemistry, admitted Autumn 2023
Ph.D. Minor, Computer ScienceBioPhD candidate in Chemistry and Computer Science, Wu Tsai Neurosciences and Sarafan ChEM-H Institute at Stanford University. Working on scientific machine learning, biomolecular modeling, and protein design for drug discovery and disease modeling.
-
Xue Zhang
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Xue Zhang is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University. She received her PhD in Biomedical Engineering from Tsinghua University in 2019 and completed research training in neuroimaging and translational psychiatry at Stanford.
Dr. Zhang’s research focuses on how individual differences in brain circuits contribute to psychiatric symptoms and treatment response. Working at the intersection of neuroimaging, computational neuroscience, and precision psychiatry, she uses functional MRI and data-driven approaches to study brain mechanisms underlying depression, PTSD, and related conditions.
A major focus of her work is understanding how rapid-acting therapeutics, including ketamine, MDMA, and psilocybin, acutely and durably modulate brain activity and connectivity. Her long-term goal is to develop personalized neuroimaging markers that can help match patients to the treatments most likely to benefit them. -
Yanxian Zhang
Postdoctoral Scholar, Endocrinology and Metabolism
BioThrough my academic training and research experience, I have cultivated a strong foundation in engineering and molecular biology. My work involves integrating diverse concepts from disciplines such as chemical engineering, protein engineering, supramolecular chemistry, and biophysics to address complex biomedical challenges. As a graduate student with Dr. Jie Zheng, my research focused on both natural and synthetic macromolecules. My research involved utilizing polymer chemistry to design biocompatible multifunctional hydrogels, as well as investigating the thermodynamics of amyloid proteins associated with neurodegenerative diseases. Leveraging my expertise in thermodynamics and supramolecular chemistry, I contributed to the study of understanding protein misfolding and aggregation. I identified sequence-independent inhibitors to prevent protein misfolding and developed a rational strategy for inhibitor design, enabling cross-interaction activity and the fluorescent detection of amyloids. Driven by a strong interest in translational research, I pursued postdoctoral training here at Stanford School of Medicine. In Dr. Danny Hung-Chieh Chou's lab at Stanford University, I received comprehensive training in peptide engineering and molecular biology. I am dedicated to addressing formulation challenges for insulin with stable ultra-concentrated and ultra-fast properties, aimed at miniaturizing insulin pumps and advancing the next-generation of insulin automatic delivery systems. This work is supported by the JDRF postdoctoral fellowship. Furthermore, I am working on therapeutics development and have successfully developed an insulin derivative that acts as a full insulin receptor antagonist. This development holds promise as a candidate for treating the rare disease of hyperinsulinism. Throughout my postdoctoral training, I have gained proficiency in grant writing, public speaking, and mentoring students. These experiences have significantly strengthened my skills as an independent investigator. Looking forward, my research goal is to develop innovative strategies that support the functionality and delivery of biological therapies.
-
Yizi Zhang
Postdoctoral Scholar, Neurosurgery
BioYizi Zhang is a postdoctoral scholar at the Neural Prosthetics Translational Lab and the Linderman Lab. Yizi’s research centers on scalable, data-driven approaches to neural encoding and decoding, with a recent emphasis on foundation models for brain-computer interfaces. Yizi is broadly interested in developing AI-assisted neuroprosthetic technologies to help individuals with paralysis communicate and interact more effectively with the world.
-
Yu Zhang
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Yu Zhang's research operates at the intersection of AI, translational neuroscience, and precision medicine. His work focuses on unraveling the complex neurobiological mechanisms underlying cognitive deficits, behavioral dysfunctions, and therapeutic responses in mental health disorders. By integrating advanced machine learning techniques with multimodal brain imaging modalities (e.g., fMRI, DTI, EEG), Dr. Zhang aims to identify neural signatures that reveal the heterogeneity of mental disorders across individuals. A central goal of his research is the development and validation of robust neurobiomarkers to improve diagnostic accuracy, refine prognostic assessments, and guide personalized treatment strategies. His work systematically characterizes brain function and dysfunction to optimize therapeutic interventions, including pharmacological treatments, psychotherapy, and neurostimulation. He is particularly focused on conditions such as Alzheimer’s disease and related dimentia, mood disorders, and neurodevelopmental disorders (e.g., ADHD, ASD), where individualized approaches are essential for improving patient outcomes.
Dr. Zhang has received multiple grants including the NIH R01, R21, Eagles Autism Foundation Translational Grant, Alzheimer's Association Research Grant (AARG), and the Knight Initiative for Brain Resilience and the Rosenkranz Foundation Grants. Beyond foundational research, Dr. Zhang is committed to bridging the gap between computational innovation and clinical application. By collaborating with clinicians, neuroscientists, and engineers, he strives to translate data-driven insights into actionable tools for real-world healthcare settings. His long-term vision is to enable mental health diagnostics and treatment to be guided by objective, biologically grounded biomarkers, thereby enhancing quality of life and long-term outcomes for individuals with psychiatric and neurological conditions.
The Stanford Precision NeuroIntelligence (SPNI) Lab, led by Dr. Zhang, is dedicated to advancing research in AI-driven neuroimaging and precision psychiatry. The lab develops and applies cutting-edge machine learning and deep learning methods to uncover neurobiological mechanisms associated with cognitive and behavioral dysfunctions, as well as treatment responses in mental health conditions. Its mission is to identify translational biomarkers that support precision diagnosis, prognosis, and targeted interventions for mood disorders, neurodevelopmental disorders, and neurodegenerative diseases. -
Yuan Zhang
Basic Life Research Scientist, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordBasic Life Research Scientist
-
Zeyuan Zhang
Postdoctoral Scholar, Hematology-Oncology
BioZeyuan Zhang, Ph.D., is a Postdoctoral Scholar at Stanford University in the laboratory of Glaivy Batusli, where he is conducting research on the evolution of antibody development against the coagulation protein factor IX in hemophilia B disease models. He earned his Ph.D. in Biomedical Science from the University of Iowa, focusing on cell and developmental biology.
Dr. Zhang’s research centers on the molecular mechanisms underlying metabolic disease, with particular emphasis on organelle dysfunction in obesity. His work has provided insights into GSNOR enzymatic activity, lysosomal dysfunction, and inflammatory stress in metabolic regulation. He has also investigated transcriptional mechanisms contributing to obesity-associated hepatic dysfunction and adipose tissue homeostasis. Prior to joining Stanford, he worked as a Scientist I at Altos Labs, where he studied hepatocyte-specific rejuvenation reprogramming in fatty liver disease.
His technical expertise includes multi-omics approaches, RNA sequencing, chromatin immunoprecipitation, high-resolution respirometry, advanced imaging techniques, and in vivo mouse models. He also has extensive experience in primary cell isolation and histological analysis.
Dr. Zhang is interested in translational research that connects molecular mechanisms to therapeutic strategies, with the goal of developing innovative treatments for metabolic diseases.
